Assessment of medication management ability in middle-aged and older adults with bipolar disorder.
(57/180)
(+info )Comparing the efficacy of interventions that use environmental supports to improve outcomes in patients with schizophrenia.
(58/180)
(+info )Initial phase 2 trial of a nicotinic agonist in schizophrenia.
(59/180)
(+info )Health belief model predicts adherence to CPAP before experience with CPAP.
(60/180)
(+info )Cognitive correlates of schizophrenia signs and symptoms: I. Verbal communication disturbances.
(61/180)
(+info )Hippocampal and amygdalar volumes in psychotic and nonpsychotic unipolar depression.
(62/180)
(+info )Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders.
(63/180)
(+info )Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial.
(64/180)
(+info )